Drug intelligence / Profile preview

norethisterone enantate + estradiol valerate

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Norethisterone enantate + estradiol valerate is a combined injectable contraceptive containing two hormones: norethisterone enantate, a synthetic progestogen (progestin), and estradiol valerate, a synthetic estrogen. Administered as an intramuscular depot injection once monthly, it provides effective contraception by suppressing ovulation and altering the endometrium and cervical mucus to prevent pregnancy. The combination is also used in hormone replacement therapy for menopausal symptoms and prevention of osteoporosis in postmenopausal women. After injection, both esters are hydrolyzed to their active forms—norethisterone and estradiol—which act as agonists at the progesterone receptor and estrogen receptor, respectively[1][4][5][7].

Brand names
MesigynaChinese Injectable No. 3EfectimesGinediolMesilarMeslartMesoceptMesygestNofertylNofertyl LafrancolNoregynaNorestrinNorifamNorigynonNostidynSexsegSolouna
Other names
norethisterone enanthate + estradiol valerate injection
02

Targets

PR (Progesterone receptor)ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on norethisterone enantate + estradiol valerate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norethisterone enantate + estradiol valerate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call